This article describes a meta-analysis of published associations between depression and
heart failure (HF) in regard to 3 questions: 1) What is the prevalence of depression among …

Immune-based therapies have revolutionized cancer treatments. Cardiovascular sequelae
from these treatments, however, have emerged as critical complications, representing new …

The heart is a highly structured organ consisting of different cell types, including myocytes,
endothelial cells, fibroblasts, stem cells, and inflammatory cells. This pluricellularity provides …

The natriuretic peptides, including human B-type natriuretic peptide (BNP), have been
implicated in the regulation of cardiac remodeling. Because transforming growth factor-β …

Classical therapy of heart failure is based on treatment of its pre-disposing/triggering factors
and of the neurohumoral activation secondary to the deterioration of cardiac function. A new …

Background—The increasing prevalence of heart failure (HF) and high associated costs
have spurred investigation of factors leading to adverse outcomes in patients with HF …

Myocardial infarction affects a large proportion in the world. This study aims to evaluate the
protective effects of vanillic acid in isoproterenol induced cardiotoxic rats. Male Wistar rats …

Heart failure (HF) with preserved ejection fraction (HFpEF) is a heterogeneous clinical
syndrome characterized by cardiovascular, metabolic, and pro‐inflammatory diseases …

Oxidative stress and inflammation are each implicated independently in the development
and progression of heart failure. Their interaction, however, is also evident throughout the …

Background Soluble ST2 is a biomarker that is elevated in certain systemic inflammatory
diseases. Comorbidity‐driven microvascular inflammation is postulated to play a key role in …